We are live on ! Find out more
NEPH icon

Nephros
NEPH

13 hedge funds and large institutions have $4.56M invested in Nephros in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

118% more capital invested

Capital invested by funds: $2.09M → $4.56M (+$2.47M)

63% more funds holding

Funds holding: 8 → 13 (+5)

2.4% more ownership

Funds ownership: 3.37% → 5.76% (+2.4%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
13
Holders Change
+5
Holders Change %
+62.5%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ISL
Ingalls & Snyder LLC
New York
+$612K
2
HighTower Advisors
HighTower Advisors
Illinois
+$385K
3
EP
Elkhorn Partners
Nebraska
+$52.6K
4
BlackRock
BlackRock
New York
+$22.8K
5
UBS Group
UBS Group
Switzerland
+$5.17K

Top Sellers

Rank Fund Capital Flow
1
SAM
Southpaw Asset Management
Connecticut
-$601K
2
Goldman Sachs
Goldman Sachs
New York
-$156K
3
Millennium Management
Millennium Management
New York
-$143K
4
BRWA
B. Riley Wealth Advisors
Florida
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
PHP
1
Parkman Healthcare Partners
Connecticut
$1.99M +$1.78M +199,724 New
ISL
2
Ingalls & Snyder LLC
New York
$1.34M +$612K +68,750 +105%
HighTower Advisors
3
HighTower Advisors
Illinois
$430K +$385K +43,210 New
William Blair & Company
4
William Blair & Company
Illinois
$341K – – –
Millennium Management
5
Millennium Management
New York
$224K -$143K -16,020 -42%
BRWA
6
B. Riley Wealth Advisors
Florida
$142K -$106K -11,878 -45%
EP
7
Elkhorn Partners
Nebraska
$59K +$52.6K +5,908 New
BlackRock
8
BlackRock
New York
$25K +$22.8K +2,562 New
UBS Group
9
UBS Group
Switzerland
$6K +$5.17K +581 +2,767%
PCM
10
Prelude Capital Management
New York
$4K +$3.27K +367 New
SFS
11
Sowell Financial Services
Arkansas
$3K +$2.71K +305 New
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Deutsche Bank
13
Deutsche Bank
Germany
$1K +$1.78K +200 New
SAM
14
Southpaw Asset Management
Connecticut
– -$601K -73,810 Closed
Goldman Sachs
15
Goldman Sachs
New York
– -$156K -19,418 Closed

NEPH Hedge Fund Activity: Q4 2019 in Review

13 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q4 2019, worth a combined $4.56M — up 118% from $2.09M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NEPH positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Ingalls & Snyder LLC, adding an estimated $612K. The largest seller was Southpaw Asset Management, exiting entirely with an estimated $601K sold.

  • 13 institutional investors held Nephros (NEPH) as of Q4 2019, up from 8 in Q3 2019.
  • Funds reported $4.56M of Nephros stock for Q4 2019, up 118% quarter-over-quarter.
  • 7 funds opened new Nephros positions in Q4 2019 and 2 closed out, a net change of +5 holders.
  • The largest Nephros buyer in Q4 2019 was Ingalls & Snyder LLC, an estimated $612K added.
  • The largest Nephros seller in Q4 2019 was Southpaw Asset Management, an estimated $601K sold.

Based on aggregated 13F filings for Q4 2019.